Search results for "Anticoagulation"
Latest research, recommendations cover diabetes, clots, and remdesivir in COVID-19
Mortality was lower in diabetes patients given sitagliptin at admission for COVID-19, ACP practice points support remdesivir, acquired thrombophilia does not predict clots, cardiac arrest survival is low, and admissions for other conditions were still way down over the summer.
https://acphospitalist.acponline.org/weekly/archives/2020/10/07/1.htm
7 Oct 2020
New guidelines cover VTE prophylaxis, diagnosis, anticoagulation, and HIT
Several guidelines related to venous thromboembolism (VTE) prevention and treatment were recently published by the American Society of Hematology, with more promised soon.
https://acphospitalist.acponline.org/weekly/archives/2018/12/05/1.htm
5 Dec 2018
COVID-19 research focuses on steroids, clots, hydroxychloroquine, zinc
Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://acphospitalist.acponline.org/weekly/archives/2020/07/29/1.htm
29 Jul 2020
Updated guidelines released on antithrombotic therapy for afib
The American College of Chest Physicians provided 60 recommendation statements in the areas of stroke risk, bleeding risk, antithrombotic therapy, and management of bleeding on oral anticoagulation, among other topics.
https://acphospitalist.acponline.org/weekly/archives/2018/08/29/5.htm
29 Aug 2018
The puzzle of submassive PE
Treating the middle of the pulmonary embolism spectrum can be tricky.
https://acphospitalist.acponline.org/archives/2020/06/the-puzzle-of-submassive-pe.htm
15 Jun 2020
Pneumonia therapies, hospital flu spread, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/08/recent-research.htm
15 Aug 2020
Apixaban linked to lower risk of serious bleeding compared to warfarin in patients with or without afib
A comparison of direct oral anticoagulants and warfarin found that apixaban had the lowest number needed to treat to avoid one extra major bleed compared to warfarin, while rivaroxaban had the lowest number needed to harm with death from bleeding.
https://acphospitalist.acponline.org/weekly/archives/2018/07/11/3.htm
11 Jul 2018
MKSAP quiz on pulmonary embolism
This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on pulmonary embolism.
https://acphospitalist.acponline.org/archives/2020/06/mksap-quiz-on-pulmonary-embolism.htm
15 Jun 2020
DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis
A meta-analysis compared the direct oral anticoagulants (DOACs) apixaban, edoxaban, and rivaroxaban to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://acphospitalist.acponline.org/archives/2023/01/04/doacs-more-effective-cost-effective-than-lmwh-for-cancer-associated-thrombosis.htm
4 Jan 2023
Frail elderly, Enterobacteriaceae infections, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2018/03/recent-research.htm
15 Mar 2018